Vor Biopharma Inc.
VOR
$16.47
-$0.78-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 395.19% | 171.40% | 133.38% | -44.14% | -32.99% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -72.58% | -82.22% | -62.93% | 17.85% | 33.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 359.21% | 348.07% | 952.21% | -41.42% | -20.00% |
| Total Current Assets | 374.69% | 156.31% | 127.05% | -42.01% | -31.46% |
|
|
|||||
| Total Current Assets | 374.69% | 156.31% | 127.05% | -42.01% | -31.46% |
| Net Property, Plant & Equipment | -91.66% | -92.43% | -99.95% | -17.29% | -16.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -46.79% | -91.13% | -92.33% | -33.88% | -33.62% |
| Total Assets | 224.81% | 51.94% | 45.05% | -34.56% | -27.88% |
|
|
|||||
| Total Accounts Payable | 240.66% | -32.75% | -66.67% | 60.52% | 84.66% |
| Total Accrued Expenses | 53.30% | 99.66% | 656.46% | 25.31% | 17.98% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -93.36% | -93.95% | -- | 7.81% | 10.05% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 35.24% | 31.33% | 325.86% | 26.60% | 19.52% |
|
|
|||||
| Total Current Liabilities | 35.24% | 31.33% | 325.86% | 26.60% | 19.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -90.15% | -90.22% | -- | -13.86% | -13.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1,259.46% | 5,480.73% | 3,832.77% | -1.71% | -2.48% |
|
|
|||||
| Common Stock & APIC | 78.57% | 30.28% | 12.19% | 12.45% | 12.78% |
| Retained Earnings | -152.30% | -574.63% | -417.44% | -31.98% | -34.38% |
| Treasury Stock & Other | 86.36% | -82.35% | 120.00% | 126.44% | 128.57% |
| Total Common Equity | -269.98% | -3,150.49% | -1,635.18% | -46.30% | -35.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -269.98% | -3,150.49% | -1,635.18% | -46.30% | -35.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -269.98% | -3,150.49% | -1,635.18% | -46.30% | -35.87% |
|
|
|||||